Ginkgo Bioworks Holdings, Inc. (DNA) NYSE

9.20

+0.185(+2.05%)

Updated at December 04 03:31PM

Currency In USD

Valuation

Market Cap509.61M
Enterprise Value415.76M
P/E Ratio-1.51
PEG Ratio0.24
Price/Sales Ratio2.78
Price/Book Ratio0.91
Enterprise/Revenue4.51
Enterprise/EBITDA-2.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.88
Operating Margin-1.93

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.54

Income Statement

Revenue227.04M
Revenue/Share3.25
Gross Profit188.49M
EBITDA-484.39M
Net Income-547.03M
Diluted EPS-10.54

Balance Sheet

Total Cash461.86M
Total Cash/Share8.3
Total Debt422.87M
Total Debt/Equity0.76
Current Ratio4.39
Book Value Per Share10.06

Price History

52-Week Change-11.67
52-Week High17.58
52-Week Low5
Moving Average 50 Days11.68
Moving Average 200 Days10

Statistics

Average Volume1.45M
Shares Outstanding54.65M
% Held by Institutions55.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:40
Last Split DateAugust 20, 2024